Alina Tanase, M.D., Ph. D.

Prof A. Tanase, MD, PhD is head of the Bone Marrow Transplantation Unit of Fundeni Clinical Institute, Bucharest, Medical Director of Fundeni Clinical Institute and President of Romanian Society of Bone Marrow Transplantation. She graduated the Faculty of Medicine in Craiova in 1994; obtained the specialization in hematology in 1999, the superspecialization in bone marrow transplantation in 2003, the PhD title in 2004, and a postdoctoral scholarship in 2010.

Prof. A. Tanase has received intensive training in bone marrow transplant in several centers, including Institute of Haematology Seràgnoli, Bologna, Italy, University Hospital of Regensburg, Germany and MD Anderson Cancer Center, Houston, University of Texas, the United States.

The field of research activity is hematopoietic stem cell transplant, with emphasis on lymphomas and graft versus host disease. Prof. A. Tanase has successfully led national and international projects on hematopoietic stem cell transplantation, she developed collaborations with international research centers such as MD Anderson Cancer Center, Houston, USA and is part of the board of the and Lymphoma Working Party from EBMT.

She succeeded to implement CAR-T therapies in adult patients in Fundeni Clinical Institute, in 2022, opening a new stage in the treatment of patients with malignant hemopathies.